HDFC Pharma and Healthcare Fund - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 21.626 ↑ 0.68%
[as on 11 August, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 11 August, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option 25.88% 0.68% 1.99% 4.67% 12.49% 27.01%----
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 24.78% 0.63% 1.75% 5.34% 13.75% 23.58% 23.75% 17.84% 25.12% 13.98%
SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth -1.39% -0.33% -0.41% 2.01% 5.47% 4.41% 10.63% 9.72% 13.16% 11.53%
SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH 2.95% -0.57% -0.66% -0.32% 0.74% 6.43% 15.42% 17.7% 19.41% 14.96%
SBI PSU Fund - REGULAR PLAN -Growth 1.32% -0.01% 0.1% -0.31% -1.78% 10.23% 23.24% 23.5% 20.01% 13.9%
SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH -3.88% -0.45% -0.53% 2.38% 2.43% -3.32% 7.28% 13.5% 15.67% 13.17%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 50.48% 0.54%

Discrete returns (monthly)

MonthOct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026
Returns 2.06% 1.12% -1.48% -4.75% 6.9% -4.45% 7.74% 5% 6.5% 3.5%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 17.33%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 August, 202621.626 0.68%
10 August, 202621.479 0.13%
7 August, 202621.452 0.47%
6 August, 202621.351 0.17%
5 August, 202621.314 0.51%
4 August, 202621.205 -0.27%
3 August, 202621.263 0.92%
31 July, 202621.069 0.08%
30 July, 202621.053 -0.3%
29 July, 202621.117 1.36%
28 July, 202620.833 -0.11%
27 July, 202620.855 1.46%
24 July, 202620.555 -0.22%
23 July, 202620.6 -0.69%
22 July, 202620.743 -1.42%
21 July, 202621.042 0.17%
20 July, 202621.006 0.95%
17 July, 202620.808 -0.87%
16 July, 202620.991 0.13%
15 July, 202620.963 0.83%
14 July, 202620.79 0.6%
13 July, 202620.666 0.02%
10 July, 202620.661 0.19%
9 July, 202620.621 1.51%
8 July, 202620.314 -1.07%
7 July, 202620.534 -0.79%
6 July, 202620.697 -0.1%
3 July, 202620.718 0.9%
2 July, 202620.533 0.87%
1 July, 202620.356

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 21.626 as on 11 August, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 25.88% as on 11 August, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 27.01% as on 11 August, 2026.